The article discusses the ability of humans to develop adeno-associated virus (AAV)-specific neutralizing anti-bodies that can block gene transfer, which references the article "Overcoming preexisting humoral immunity to AAV using capsid decoys," by F. Mingozzi and colleagues in the 2013 issue of the journal "Science Translational Medicine."